Home / Vancomycin / United States
US ATC J01XA01 · updated 2 Nov 2026
Vancomycin shortage in United States
Is there a Vancomycin shortage in United States?
Yes. As of 2 Nov 2026, 1 Vancomycin product is reported short in United States, the first since 14 Nov 2025. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, Italy, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01) discontinuation | Hospira, Inc., a Pfizer Company | 14 Nov 2025 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).